Background Occult breast lesions are being successfully targeted by means of Radioactive-guided Occult Lesion Localization (ROLL). Several reports demonstrate suitability of ROLL technique to excise non-palpable breast lesions with immediate advantages.
Introduction
Impalpable breast cancer is increasingly being detected due national use of breast screening programs. Several localization techniques to guide surgical excision have been reported: 1,2 among them, Radioactive-guided Occult Lesion Localization (ROLL) is gaining popularity due to several previously reported advantages. 3-8 ROLL was shown to be associated with a reduced excision volume and more accurate centricity of lesion within the surgical specimen. 3,8 ROLL is a quicker, more accurate and patient-friendly technique, which provides better cos-metic results and a higher percentage of tumor-free margins. 9 An online literature search (Pub Med) using terms: ROLL, long-term outcome, radioisotope localization, breast cancer and recurrence was performed and few reports were noted. We have analyzed our consecutive prospective series and hereby report the recurrence rates.
Materials and methods
ROLL excision for impalpable breast cancer is in practice at our breast unit since December 2002. All core biopsy Original Article 48 proven but impalpable cancers are localized prior to surgery. An injection of 0.2 ml injection of 99m Tc (t/2 = 6 h) suspended in macroaggregate of albumin was performed 1-4 hours prior to but on the day of surgery. It contained approximately 90,000 particles and had a particle size of 10-90 μm. The radioactivity administered was 1 MBq equal to 0.02 msv (i.e. the same dosage as for a chest X-ray). At surgery, center of the target lesion identification was facilitated by gamma probe. An intense persistent high pitched audible signal of radioactivity as detected with gamma probe was used (Fig. 1) to guide excision biopsy.
Satisfactory excision of the target tissue confirmed with a specimen X-ray (Fig. 2) . The abnormality in the specimen should correlate with suspicious abnormality in the mammogram (Fig. 3) . Cavity thus created after excision checked for any residual radioactivity (Fig. 4) . Absence of residual audible signals using gamma probe indicates excision of target tissue.
Our aim is to remove the target lesion with 1 cm of healthy breast tissue all around; this is followed by selective shaving of the cavity. All specimens were marked with standard marking stitches (Fig. 5) to orient the specimen for pathological assessment.
Patients with positive margins (tumor cells within 1 mm excision margin) and positive cavity shavings (tumor cells in cavity shaving) were offered re-excision. Patients having completed at least 22 months clinical follow-up from first cancer surgery are included in the study. The breast-sparing procedure was followed by standard external beam adjuvant radiotherapy (45 Grey over 6 weeks course).
Our unit follow-up protocol included: clinician administered 6 monthly breast examinations and 18 monthly mammograms; chest X-ray, bone scan and haematochemical evaluation were performed when clinically indicated. Brain or liver imaging was under-taken when clinical or biochemical suspicion arose. Lesions clinically or radiologically suspicious for local recurrence were pathologically evaluated. The occurrence of systemic recurrence detected on imaging was not necessarily confirmed with a pathological diagnosis. Information regarding 
